Dental Radiology and Dental Imaging Devices Market Research Report- Forecast till 2030

 Dental Radiology and Dental Imaging Devices Market

The dental radiology and dental imaging devices market is anticipated to reach USD 3452.8 Million by 2030 at 7.90% CAGR during the forecast period 2022-2030.

Dental radiology and imaging devices are used for diagnosis and treatment of dental problems with the help of x-rays, radioactive substances, and other forms of radiant energy. The market is majorly driven by the technological advancements in the dental equipment, high adoption of digital dental Radiology and imaging systems, growth in aging population, and dental surgeries gaining impetus. However, high price of digital Radiology systems, and lack of reimbursement in dental care is expected to restrain the growth of this market.

There are various number of dental imaging devices present in the market. The dental Radiology and dental imaging device market is segmented by devices into dental Radiology and dental imaging. Dental radiology devices segment includes phosphor storage plates, portable x-rays, accessories, and other devices. Dental Imaging devices segment includes cameras, and dental imaging software. Demand of dental radiology and imaging devices is increasing due to an extensive use of radiology in dentistry and availability of cost effective technologies for treatment of dental problems.

Increasing demand for imaging technology in orthodontics is majorly attributed to the growth of this market as it enable better magnification and less geometric distortion, super imposed structure and varying head position. Similarly the increasing use of dental imaging techniques in endodontic due to its 3d image and better resolution is increasing the market. Also increased accuracy, less efforts and better results are another integral parts of CBCT dental imaging technique stealing the conventional methods market.

Major Key Players:

Carestream Health (U.S), Dentsply Sirona (U.S), Flow Dental (U.S), KaVo Dental GmbH (Germany), LED Medical Diagnostics Inc, (Canada), Midmark Corp. (U.S), 3M (U.S), Nobel Biocare (Part of Danaher corporation) (Switzerland) and others are some of the prominent players at the forefront of competition in the global dental radiology and dental imaging devices market and are profiled in MRFR Analysis. 

Regional Analysis

Geographically, the regional dental imaging technology market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

The North America dominated the global dental radiology and dental imaging devices market with the U.S. holding the largest market share owing to numerous developments in the medical sector.

In European market is expected to exhibit positive growth during the forecast period. Whereas Asia Pacific is expected to be a growing market for Dental radiology and dental imaging devices market and expected to grow at a rapid rate. The developing countries such as China and India are leading this market due to the fast growing healthcare sector and large unmet needs over the forecast period. The Middle East & African market especially, the African region is expected to witness a poor growth owing to the lack of knowledge in medical sector, and less development in medical facilities in Middle East & Africa will have limited growth in the market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Malocclusion Market Research Report - Global Forecast till 2030

 Malocclusion Market

Malocclusion Market size is expected to reach USD 40 Billion by 2030 at 6.9% CAGR during the forecast period 2022-2030.

Malocclusion is the misalignment of teeth. Malocclusion is most often hereditary, but it can also occur due to other reasons i.e. childhood habits such as thumb sucking, pacifier use beyond age 3, and others, extra teeth or lost teeth, ill-fitting dental fillings, and jaw tumors. There are three major classes of malocclusion i.e. Class 1, Class 2, and Class 3.

Increasing prevalence of malocclusion, favorable reimbursement scenario, and rising trend of cosmetic dentistry are the key factors driving the malocclusion market.

However, lack of technological awareness and complications associated with malocclusion treatment may hinder the growth of the market to an extent. The lack of technological awareness is mainly attributed to the slow adoption rate of new technology by the dentists.

Taste the market data and market information presented through more than 296 market data tables and figures spread over 251 pages of the project report.

Major Key Players:

Some of key the players in the malocclusion market are 3M, A-dec Inc., Adenta GmbH, Align Technology, Inc, American Orthodontics, Biolase, Inc., Carestream Health, Inc., Danaher, DENTAURUM GmbH & Co. KG, Dentsply Sirona, G&H Orthodontics, Henry Schein, Inc., Midmark Corp., Patterson Companies, Inc., Planmeca OY, Rocky Mountain Orthodontics, Septodont Holding, TP Orthodontics, Inc, Ultradent Products Inc., Zimmer Dental Inc., and others.

Segment Analysis

The global malocclusion market is segmented on the basis of class, treatment, and end user.

On the basis of the class, the market is classified into class I, class II, and class III.

On the basis of the treatment, the market is segmented into orthodontic braces, surgery, and others. The orthodontic braces segment is further sub-segmented into metal braces, ceramic braces, clear aligner, and others.

On the basis of the end -users, the market is segmented into the hospital and clinics, dental clinics, and others.

Regional Analysis

The Americas dominate the malocclusion market owing to the improvement in reimbursement scenario, high healthcare expenditure, and the presence of the leading players in the region. According to the American Dental Association, in the United States, Maryland, Utah, Arkansas, and Massachusetts have the highest Medicaid FFS reimbursement rates i.e. 79.3%, 75.3%, 75.2%, and 74.1% respectively, whereas, Wisconsin, California, Washington, Maine, and Iowa have the lowest coverage relative to private dental insurance reimbursement rates.

Europe holds the second position in the malocclusion market. It is expected that the support provided by the government bodies for research & development, increasing healthcare expenditure, and rising prevalence of malocclusion are propelling the growth of the malocclusion market in the European region. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and then United Kingdom with EUR 223 billion.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.

The Middle East and Africa hold the least share of the malocclusion market owing to the presence of poor and slow developing countries, especially, in the African region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Metagenomic Sequencing Market Global Synopsis, Future Scope, Top Key Players and Forecast to 2030

 Metagenomic Sequencing Market

The Metagenomic Sequencing Market is anticipated to reach USD 1,659.22 Million by 2030 at 17.20% CAGR during the forecast period 2022-2030

Metagenomics sequencing, also known as environmental or community genomics is an approach that allows insight to be gained into community biodiversity and function. In the process of metagenomics sequencing, the DNA of the specified host microorganism is extracted and cloned directly from the microorganism using genetic analyses of DNA.

Currently, the metagenomic sequencing market is growing pervasively. The dominant factors driving this growth include the rising awareness of genetic disorders, advanced technological platforms, and the availability of improved genomic tools. Moreover, the continually dropping prices of this process are escalating the market on the global platform, encouraging people to undergo the genetic tests.

The function of metagenomic sequencing which is to sequence the genomes of untargeted cells in a community in order to elucidate community composition and function helps to understand the several types of cells in a community and what organisms are present in their physiology.

Research using the metagenomic sequencing taps into several fields due to the broad existence of large microbial communities. For instance; the study of soil microbiota has led to advances in understanding and treating plant pathogens. Whereas. In human gut microbiota, the use of metagenomics discovered how common antibiotic genes are in the gut bacteria.

The market demonstrates vast opportunities for service providers and companies with a great scope of expanding to enter the untapped regions by making these procedures affordable.

Additional factors fostering the growth of the market include the use of advanced bioinformatics tools, high throughput screening (HTS) methods, recovery of novel drugs, and the development of cost-effective technologies such as next-generation sequencing (NGS).

Major Key Players:

Players leading the global metagenomic sequencing market include Enterome Bioscience (France), GATC Biotech AG (Germany), Aperiomics, Inc. (U.S.), Illumina Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland), Second Genome Therapeutics (U.S.), SciGenom Labs Pvt. Ltd. (India),  Quest Diagnostics Incorporated (U.S.), GenapSys, Inc. (U.S.), Freenome Inc. (U.S.), COSMOSID (U.S.), Beijing Genomics Institute (China), Pacific Biosciences (U.S.), Biomatters Ltd. (New Zealand), Oxford Nanopore Technologies Inc. (UK), Thermo Fisher Scientific Inc. (U.S.), CLC Bio (Qiagen) (Denmark), DNAStar Inc. (U.S.), Agilent Technologies Inc. (U.S.), Macrogen Inc. (South Korea), Knome Inc. (U.S.), and Helicos BioSciences (U.S.) among others.

Segment Analysis

MRFR has segmented the report into four key dynamics for an easy grasp;

By Technology: Sequencing and Bioinformatics among others.

By Application : Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Ecology, and Agriculture among others.

By End-user : Hospitals, Research Institutes, and Specialized Clinics among others.                                                                 

By Regions :  North America, Europe, Asia Pacific, and the Rest-of-the-World (RoW).

Regional Analysis

The North American region leads the global metagenomic sequencing market owing to the presence of global players who are focused on introducing the procedures with innovative technology. Encouraging governmental support for R&D activities in healthcare and metagenomic sequencing tests is acting as a significant tailwind that is pushing up the market.

Additional factors encouraging the growth of the market include increased uptake of advanced technologies in the next generation sequencing procedures and its increasing applications and high healthcare expenditures.

The metagenomic sequencing market in the US backed the increasing demand for metagenomic sequencing, contributes to the growth of the regional market majorly. Heading with the rising demands for metagenomic sequencing procedures, the region will create a larger revenue pocket in the global metagenomic sequencing market by 2023.

Heading with the significant advancements of technologies and their wide uptake in the medical sector, the metagenomic sequencing market in the European region holds the second position in terms of size.

Moreover, the presence of a flourishing medical devices market and rising healthcare expenditure in the region will facilitate the growth of the market. Also, factors such as support and funding from public & private sectors for research & development impacts the market growth in the region positively.

Furthermore, the availability of low-cost metagenomic and NGS procedures and their rising adoption by research laboratories are driving the growth of this market.

The Asia Pacific region heading with the increasing prevalence of genetic disorders has emerged as a promising market for metagenomic sequencing. The large unmet clinical needs are attracting the foreign investors and global players to focus on this region to expand the network that is helping them to capture major share of the market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Sentinel Node Biopsy Market Global Demand, Growth, Top Key Players and Forecast to 2030

 Sentinel Node Biopsy Market

The global sentinel node biopsy market is growing pervasively mainly due to the increasing prevalence of various types of cancer including melanoma, colon cancer, breast cancer, esophageal cancer, head and neck cancer among others. Moreover, the spreading awareness towards the advantages of sentinel node biopsy escalates its market on the global platform.

The Sentinel Node Biopsy Market is projected to reach at 4.90% CAGR during the forecast period 2022-2030.

Additional factors propelling the growth of the market include the changing lifestyle led by the growing urbanization & industrialization. Improving economic conditions worldwide are defining the growth of the sentinel node biopsy market, enabling access to the quality of life & to the improved healthcare. Furthermore, factors such as increasing number of biopsy procedures and rising demand for new techniques for the diagnosis of cancerous growth provide significant impetus to the market growth.

On the other hand, factors such as prohibitive costs associated with the biopsy and the large unmet need are some of the key factors impeding the market growth, especially in the developing nations. Nevertheless, factors such as the availability of new products and services and the presence of well-established market players in the developing as well as developed countries will support the market growth, filling up the demand and supply gap.

Major Key Players:

Key players leading the global sentinel node biopsy market include Devicor Medical Products, Inc. (Germany), C. R. Bard, Inc. (U.S.), Hilfe Engineering Corporation (India), Intramedical Imaging LLC (U.S.), KUB Technologies, Inc. (U.S.), Surgic Eye (Germany), and Navidea Biopharmaceuticals, Inc. (U.S.) among others.

Segment Analysis

The MRFR analysis is segmented into four key dynamics for enhanced understanding.

By Product          : Breast Localization Wire, Tissue Marker, Gamma Probe, and Drainage Catheters, liquid biopsy among others.

By Indication:  Breast Cancer, Melanoma, Colon Cancer, and Esophageal Cancer among others.

By End-user        : Hospitals & Clinics, and Diagnostic Centers among others.

By Regions          : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Regional Analysis

The North American region, heading with the increasing number of market players offering biopsy devices and instruments, accounts for the leading market for sentinel node biopsy, globally. Factors such as the extensive and early uptake of medical technology for advancing medical devices and the increasing governmental support for R&D activities alongside the high health care expenditures substantiate the market growth in the region.

Furthermore, the increasing number of women suffering from breast disorders and rising prevalence of breast cancer along with the availability of quality care drives the growth of the regional market. With the constant developments by companies operating in cancer diagnostics, the market is expected to create the major revenue pocket during the review period.

The sentinel node biopsies market in the European region led by the increasing emphasis on the development of advent diagnostic devices, accounts for the next largest market, globally. Moreover, factors propelling the growth of the regional market include rising government support with the increased funding for R&D activities in the field of oncology and the rising numbers of specialty services offered by various healthcare providers.

Germany leads the European sentinel node biopsies market owing to an increasing demand for cancer diagnosis.  Whereas France and the U.K heading with the availability of tertiary care facilities in these countries and rising healthcare expenditures, secure second and third position, respectively.

The Asia Pacific region is emerging as a  profitable market for Sentinel Node biopsies, growing rapidly. Increasing incidents of breast cancer is a key driving factor fostering market growth.  Furthermore, factors such as the increasing demand for quality devices in healthcare and rapidly developing healthcare technology are fuelling the market growth in the APAC region, leading to increased use of advanced biopsy equipment.

India and China led by the presence of the highly skilled workforce and the increasing demand for biopsy procedures in hospitals and specialty care centers, exhibit enormous growth opportunities.  Moreover, growing occurrences of chronic diseases, an increase in the number of women suffering for reproductive disorders, and increasing expenditure on surgical procedures in developing economies throughout the APAC foster the growth of the regional market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Lazy Eye Market, Opportunities, Top Key Players and Forecast to 2030

 Lazy Eye Market

The Lazy Eye Market is anticipated to reach USD 4,576.67 Million by 2030 at 5.20% CAGR during the forecast period 2022-2030.

Increasing prevalence of the lazy eye diseases, growing child population, rising healthcare expenditures, and increasing R&D by the major market players are estimated to be the major drivers governing the market growth during the forecast period. However, lack of awareness and unavailability of the effective treatment procedures may restrain the market growth during the projected period.

Major Key Players:

The key players in the global lazy eye market are inclusive of Pfizer Inc. (U.S.), TCI Chemicals (India) Pvt. Ltd. (India), Adwia Pharmaceuticals Co. (Egypt), 3M (U.S.), Bausch & Lomb Incorporated. (U.S.), Rebion (U.S.), Vivid Vision, Inc. (U.S.), Johnson and Johnson Services, Inc. (U.S.), and others.

Segment Analysis

The global lazy eye market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of the type, the market is segmented into strabismic amblyopia, refractive amblyopia, deprivation amblyopia, and others. On the basis of the diagnosis, the market is segmented into general eye test, squint test, and others. On the basis of the treatment, the market is segmented into corrective eyewear, eye patches, surgery, atropine eye drops, and others. The corrective eyewear segment is sub-segmented into glasses, contact lenses, and others. On the basis of the end-users, the market is segmented into eye care clinics, hospitals, retail pharmacies, and others.

Regional Analysis

The Americas lead the global lazy eye market. Presence of the well-developed healthcare sector, growing child population, and rising healthcare expenditure are the driving factors for the market growth. Additionally, the presence of the major players within the region boosts the market. Europe is estimated to be the second in the global lazy eye market owing to the availability of the funds for research and huge patient population. The Asia Pacific is the fastest growing region for the market. Developing healthcare sector and rising per capita healthcare expenditure are the major drivers of market growth within the region. The Middle East & Africa holds the least share in the lazy eye market owing to the poor availability of the healthcare services and low per capita healthcare expenditures within the African region. The Middle East region holds a majority of the market of the Middle East and Africa due to the presence of developed economies like Kuwait, Qatar, Dubai, Oman besides others. Moreover, the per capita healthcare expenditure within the region is high providing favorable backgrounds for market growth.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pediatric Healthcare Market Business Growth | Size, Value Share, Industry Segment and Forecast to 2027

 Pediatric Healthcare Market

The Middle-East and Africa Pediatric Healthcare Market has been evaluated as progressively growing market and it is expected that the market will continue to grow at same pace in the near future. Pediatric is field of medicine which concern with physical, mental and social health of infants, children and adolescents. Pediatric drugs manufacturers are investing in R&D to develop new drugs while pediatric equipment manufacturers are also developing innovative and technologically advanced products for the market. Many hospitals are providing wide range of healthcare services in Middle East and Africa region. Due to increase in per capita income, the spending on healthcare also increasing in this region. The diseases like diabetes, asthma, and obesity are rising rapidly that is major market driver for pediatric healthcare in this region. Improving healthcare infrastructure, top class medical facilities and availability skilled medical professionals are leading the growth for the pediatric healthcare market in this region. Government are also considering healthcare as priority and taking many initiatives to improve healthcare sector which is major driver for the market. Middle East and Africa is expected to grow by 10% annually and which is good factor for the growth of overall healthcare industry. Due to cost efficient and top class medical facilities, medical tourism is also rising in Middle East and Africa. Medical tourism also helps many industries to grow such as hotel industry, aviation industry, tourism and local vendors. 

The Pediatric Healthcare Market will obtain a valuation of USD 63.6 billion and a CAGR of 4.1 % in the forecast period. 

 However, some facts are inhibiting the growth of the market in this region includes lack of responsiveness towards the pediatric healthcare due to lack of access to healthcare facilities and skilled medical professionals  mainly in African countries etc.

Major Key Players:

There are plenty of large and small market players which operate in this market all over the Middle East and Africa region, such Novartis AG (Switzerland), AstraZeneca (UK), Janssen Global Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE)

Segment Analysis

Middle East and Africa Pediatric healthcare Market has been segmented on the basis of type of diseases which comprise Short term diseases, chronic diseases, and others.

On the basis of Therapeutics which cardiology, allergy and immunology, gastroenterology, infectious disease, and others.

On the basis of treatment it segmented into medication, surgery, and pediatric home healthcare.

Regional Analysis

Considering the scenario of the Middle East and Africa market, UAE region is believed to be the largest market for Middle-East and Africa Pediatric healthcare. Moreover, Saudi Arabia market is also growing and second largest market for Pediatric healthcare. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Pediatric healthcare during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Oligonucleotide Synthesis Market 2022 | Size, Value Share, Latest Trend, Key Player Review, Business Prospect and Forecast to 2030

 Oligonucleotide Synthesis Market

The oligonucleotide synthesis market is expected to gain a market value of USD 27,109.8 million by 2030 at a CAGR of 16.5% over the forecast period of 2022-2030. The market over the review period is also expected to earn substantial valuation. The chemical synthesis of the nucleic acids with definite chemical structures is known as oligonucleotide synthesis. Its ability to produce results regarding customized nucleotides rapidly through inexpensive methods is making it choicest preference for a lot of research laboratories that are spending heavily in developing biotechnologies. The desired oligonucleotide requires a perfect oligonucleotide chain which can easily be made in laboratories. The completion of the chain sees a release from the solid phase to the solution, deprotected, and collected. MRFR in their recent report on the oligonucleotide synthesis market distinctly studied segments with their proper valuation both value-wise and volume-wise to understand the market comprehensively. Factors that can impact the market in the coming years have also been included for a critical overview of the oligonucleotide synthesis market.

Ventures and investments from big companies in the oligonucleotide synthesis market can prove beneficial in the coming years. Gene study can provide much-needed traction, and the market can witness substantial rise during the forecast period. But the cost associated with it can be a major factor, and lack of adept hands can be a market deterrent. 

Major Key Players:

Prominent players functioning in the oligonucleotide synthesis market, as described by MRFR, are GE Healthcare (U.S.), Integrated DNA Technologies, Inc (U.S), Eurogentec S.A (Belgium), Sigma-Aldrich Corporation (U.S.), Bioautomation Corporation (U.S.), Agilent Technologies Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eurofins Genomics (Germany), L.G.C Biosearch Technologies (U.S.), Nitto Denko Avecia Inc. (Japan), and others.

Segment Analysis

MRFR, for a better understanding of the oligonucleotide synthesis market, segmented the market by product type, application, and end-users.

Based on the product type, the oligonucleotide synthesis market can be segmented into synthesized oligonucleotides, reagents and equipment. The synthesized oligonucleotides segment has a substantial hold over the market.

Based on the application, the oligonucleotide synthesis market can be segmented into library preparation, diagnostic, research, therapeutics, genetic testing, gene synthesis, drug target screening, and others. Drug target screening is quite popular as it gets substantial traction from the pharmaceutical sector.

Based on the end-users, the oligonucleotide synthesis market can be segmented into academic research institutes, diagnostic laboratories, and pharmaceutical & biotechnology companies. Diagnostic laboratories are expected to record considerable growth during the forecast period.

Regional Analysis

Region-specific segmentation of the oligonucleotide synthesis market, as discussed in the MRFR report, includes North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The rise of North America can be attributed to the constant search for better treatment. The robust healthcare structure and the infrastructure of the research centers are quite indicative of that. Regional endeavor for such things is getting mostly driven by chronic diseases such as cancer and diabetes. Governments and private investors are equally funding for innovation in the sector, and it can take the regional market further ahead.

Europe is getting driven by the same intents like that of North America and is getting amply backed by research centers and government initiatives. Funding for the regional market is not a big problem as many pharmaceutical companies from the region are investing substantially in understanding the gene sequence to develop better drugs. The APAC region is expected to rise significantly as many of the global titans are looking at the region as a possible investment opportunity. Infrastructural benefits and low cost of resources are some alluring factors that are controlling the market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Catheter Securement Device Market Global Analysis 2022 to 2027 | Industry Demand, Size, Share, Trend, Key Players Review

 Catheter Securement Device Market

Growing demand for catheter securement devices in minimally invasive surgeries and technological advancement is expected to register a CAGR of ~8.2% during the forecast period of 2021 to 2027

The global catheter securement device market is driven by several factors, such as increasing demand forcatheter securement devices used in surgeries, rising incidence, and prevalence ofchronic illness.Furthermore, rising R&D activities for catheter securement devices areprojected to drive the market in the forecast period.

Major market players such as 3M company, B. Braun Melsungen AG, C.R. Bard, Inc., ConvaTec Group plc, and Baxter International Inc.are dominating the global catheter securement device market. Theseprominent players are involved in strategic agreements, new product launches, innovations, and joint ventures to sustain their market positions.For instance, in May 2019, Dale Medical Products, Inc. (US) introduced the Hold-n-Place catheter securement device, which is soft, comfortable, and has a flexible design with no hard plastic parts. It provides complete antimicrobial protection.

Major Key Players:

Some of the key players in the global catheter securement device market are 3M Company (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), C.R. Bard, Inc. (US), Centurion Medical Products (US), ConvaTec Group plc (UK), Merit Medical Systems, Inc. (US), Smiths Medical (US), TIDI Products, LLC (US), M.C. Johnson Company, Inc. (US), DeRoyal Industries, Inc. (US), Cardinal Health (US), BioDerm Inc. (US), Starboard Medical, Inc. (US), and Pepper Medical (US).

FREE SAMPLE

Segment Analysis

The global catheter securement device market has been segmented into product type, application, end user, and region.

By product type, the market has been segregated into arterial, central venous, peripheral, chest drainage tubes, abdominal drainage tubes, epidural, and all-site securement devices.

Central venous is further segmented intoperipherally inserted central catheter (PICC), subclavian, midlines, femoral, portal, and jugular.Peripheralis further segmented into foley catheter securement device, nasogastric tubes,endotracheal tubes,ventriculoperitoneal, and continuous nerve blocks. The abdominal drainage tubessegment is further segmented intopercutaneous endoscopic gastrostomy, jejunal, and umbilical. The peripheral securement devices segment held the majority share in 2020 due to the extensive use of peripheral securement devices for blood transfusions and the administration of intravenous fluids&other medications after surgery.

Based on application, the catheter securement device market is segmentedintocardiovascular,radiology, general surgery, urological, respiratory, and gastric&oropharyngeal.The cardiovascular segment held the largest share in 2020 due to the rising prevalence of cardiovascular disorders such asatrial septal defect, heart valve disease, and coronary artery diseaseacross the globe.

Based on end user, the catheter securement device market is segmented into hospitals & clinics, home healthcare, and diagnostic centers.The hospitals & clinics segment held the largest market share in 2020 due toalarge number of hospitals present across the globe anda vastnumber of surgical procedures performed across these facilities.

Regional Analysis

The market has been divided, by region, into North America, Europe, Asia-Pacific, and the Rest of the World. 

North America is likely to dominate thecatheter securement device market in 2020,owing to thehigh prevalence of chronic diseasesand the presence of major industry players across the region. In addition, a large number of foreign patients prefer surgical procedures to be conducted in the US due to the easyavailability of high-end advanced resources and well-established healthcare infrastructure. Furthermore, according to the Centers for Disease Control and Prevention (CDC), heart disease was the leading cause of death in the US from 2015 to 2020.Thus, the rising number of patients suffering from heart diseases in the USmay increase the demand forheart-related surgeries and procedures, which, in turn, is likely to increase the demandfor catheter securement devices.

Europe holds the second-largest position in the catheter securement device market due to the increased adoption of minimally invasive surgeries across the region. In addition, countries such as Germany, France, Italy, Spain, and the UK have a large number of aging population, supporting the growth of the catheter securement device market.

Asia-Pacific is anticipated to be the fastest-growing regional market during the forecast period due to increasing investment in healthcare infrastructure, improving healthcare facilities. High mortality rates due to chronic diseases such as heart diseases, respiratory diseases, urinary diseases, and diabetesare creating demand for catheter securement devices and driving the region's market growth.

The growth ofthe catheter securement device market in the Rest of the World is attributed to increasing public health awareness and government initiatives to bring more advanced technologies of catheter securement devicesinto the region.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Gene Therapy Market Size, Share, Top Key Players Update, Business Opportunity and Global Forecast to 2030

 Gene Therapy Market

Gene therapy is a technique in which a piece of DNA is incorporated into the cell via a vector. The key players are investing in the manufacturing of cell and gene therapy treatments due to its target specificity. The gene therapy is mainly of two types, somatic gene therapy, and germline gene therapy, depending on the type of cells its targets.

Gene Therapy Market is expected to rise at a CAGR of 23.30%, with a value of USD 524 million during the estimated the forecasting year of 2022-2030.

The growth of the global gene therapy market is attributed to various factors such as robust product pipeline, increasing investment by key players, and high prevalence of target diseases and demand for innovative medication. However, the high cost of product development and stringent regulatory policies are expected to curb the growth of the global gene therapy market. The global gene therapy market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the key players in the global gene therapy companies are Amgen, Inc. (US), Novartis AG (Switzerland), Spark Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), uniQure N.V. (Netherlands), Orchard Therapeutics plc (UK), Celgene Corporation (US), Bristol-Myers Squibb Company (US), Thermo Fisher Scientific Inc. (US), CEVEC (Germany), and Lonza (Switzerland).

Segment Analysis

The global gene therapy market has been segmented based on product, indication, and end user.

The market, based on product, has been divided into kymriah, luxturna, yescarta, zolgensma, strimvelis, zynteglo, imlygic, and others.

The global gene therapy market has on the basis of indication is segmented, into oncology, genetic diseases/ disorders, and others. The oncology segment is expected to hold the largest market share and to be the fastest-growing segment due to high prevalence of cancer and robust pipeline for cancer gene therapy.

The end-user segments of the market are hospitals & clinics, specialty treatment centers, and others. The hospitals & clinics segment is expected to hold the largest market share due to increasing number of hospitals. Also, hospitals are generally the first treatment choice for diseases.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of gene therapy and rising per capita healthcare expenditure. The gene therapy market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European gene therapy market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The gene therapy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing number of patients and raising awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The gene therapy market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Durable Medical Equipment Market Top Key Players Review 2022 | Fast Forward Research

 Durable Medical Equipment Market

Durable Medical Equipment or home medical equipment provides therapeutic benefits to patients. They are easy to use and does not need any special skill or training thus can easily be managed by a caretaker or a family member of the patient. Increasing per capita income, healthcare expenditure and aging population in Middle East and Africa are driving the DME market’s growth.

The Durable Medical Equipment Market is projected to reach USD 30,0560 Million by 2030 at 6.4% CAGR during the forecast period 2022-2030.

The Middle East and Africa healthcare sector is growing by 10% annually and it comprise 2% of the total global healthcare expenditure. Huge Investment in R&D by DME manufacturers are leading to more innovative product development. Developing infrastructure, government initiatives, extended insurance coverage and increasing awareness are major drivers of this market. Growing number of road accidents resulting in accident disability is another factor which has given a growth to the market. There is a wide range of Durable Medical Equipment (DME) present in the market making this market competitive. Middle-East and Africa Durable Medical Equipment (DME) Market was around US$ 3.48 billion in 2015 and is expected to reach US$ 4.65 billion by 2022 which has been growing at a CAGR of 4.2% and is expected to maintain this growth rate in future as well. Factors that are responsible for the growth of this market includes high cost of some products, lack of access or availability of products in some countries, lack of knowledge etc.

Major Key Players:

There are plenty of large and small market players which operate in this market all over Middle East and Africa region, such as Invacare Corporation (US), Medical Depot, Inc. (US), The Braun Corporation (US), Sunrise Medical (Germany), Permobil (Sweden), Medline Industries, Inc. (US), Compass Health Brands (US), ArjoHuntleigh (Sweden), Hill-Rom (US) and GF HEALTH PRODUCTS, INC. (US)

Segment Analysis

Middle-East and Africa Durable Medical Equipment market has been segmented on the basis of product type which comprise blood pressure monitors, blood glucose monitors, ventilators, personal mobility devices, traction equipment, wheel chairs, respiratory devices, portable medical equipments and others. On the basis of end user, the market is segmented into hospitals and clinics, healthcare institutions, research centers, home healthcare and others.

Regional Analysis

In the Middle-East and Africa Durable Medical Equipment Market scenario, Saudi Arabia region is believed to be the largest market.  Moreover UAE market is also growing and is the second largest market for DME. On the other hand, Egypt’s market of DME in these regions is expected to grow at a steady pace during the forecasted period. Rest of Middle East and Africa region is likely to have a limited but steady growth of the DME market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com